Manifestations of West Nile neuroinvasive disease

Reviews in Medical Virology

Volumn 16, Issue 4, 2006, Pages 209-224

  Sejvar, James J ^a   Marfin, Anthony A ^b  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; AMIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIVIRUS AGENT; IMMUNOGLOBULIN; IMMUNOMODULATING AGENT; N DIETHYL M TOLUAMIDE; OMR IGG AM; RIBAVIRIN; UNCLASSIFIED DRUG;

ANXIETY; APATHY; CHORIORETINITIS; CLINICAL TRIAL; DEMYELINATING NEUROPATHY; DEPRESSION; DRUG INHIBITION; DRUG MECHANISM; DRUG TOLERANCE; ECOLOGY; ENCEPHALITIS; ENDEMIC DISEASE; EPIDEMIC; FEVER; GUILLAIN BARRE SYNDROME; HUMAN; MENINGITIS; MENTAL DISEASE; NEUROLOGIC DISEASE; NONHUMAN; PATHOGENESIS; POLIOMYELITIS; REVIEW; SYMPTOMATOLOGY; VIRUS INFECTION; VIRUS TRANSMISSION; WEST NILE FLAVIVIRUS;

ANIMALS; CHORIORETINITIS; ENCEPHALITIS, VIRAL; HUMANS; POLIOMYELITIS; WEST NILE FEVER; WEST NILE VIRUS;

EID: 33746472506     PISSN: 10529276     EISSN: None     Source Type: Journal    
DOI: 10.1002/rmv.501     Document Type: Review

References (122)

1. Petersen LR, Marfin AA, Gubler DJ. West Nile virus. Jama 2003; 290(4): 524-528.
2. Campbell GL, Marfin AA, Lanciotti RS, Gubler DJ. West Nile virus. Lancet Infect Dis 2002; 2(9): 519-529.
3. Granwehr BP, Lillibridge KM, Higgs S, et al. West Nile virus: where are we now? Lancet Infect Dis 2004; 4(9): 547-556.
4. Petersen LR, Marfin AA. West Nile virus: a primer for the clinician. Ann Intern Med 2002; 137(3): 173-179.
5. Centers for Disease Control. West Nile virus activity-United States, November 20-25, 2003. MMWR Morb Mortal Wkly Rep 2003; 52(47): 1160.
6. Nash D, Mostashari F, Fine A, et al. The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med 2001; 344(24): 1807-1814.
7. O'Leary DR, Marfin AA, Montgomery SP, et al. The epidemic of West Nile virus in the United States, 2002. Vector Borne Zoonotic Dis 2004; 4(1): 61-70.
8. Smithburn K, Hughes T, Burke A, et al. A neurotropic virus isolated from the blood of a native of Uganda. Am J Trop Med 1940; 20: 471-492.
9. Chambers TJ, Halevy M, Nestorowicz A, Rice CM, Lustig S. West Nile virus envelope proteins: nucleotide sequence analysis of strains differing in mouse neuroinvasiveness. J Gen Virol 1998; 79(Pt 10): 2375-2380.
10. Monath T, Heinz F. Flaviviruses. In Field's Virology (3 edn). Fields B, Knipe D, Howley P, et al. (eds). Lippincott-Raven: Philadelphia, 1996; 961-1034.
11. Lanciotti RS, Roehrig JT, Deubel V, et al. Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States. Science 1999; 286(5448): 2333-2337.
12. Parks JJ, Ganaway JR, Price WH. Studies on immunologic overlap among certain arthropod-borne viruses. III. A laboratory analysis of three strains of West Nile virus which have been studied in human cancer patients. Am J Hyg 1958; 68(2): 106-119.
13. Nir Y, Goldwasser R, Lasowski Y, Margalit J. Isolation of West Nile virus strains from mosquitoes in Israel. Am J Epidemiol 1968; 87(2): 496-501.
14. Savage HM, Ceianu C, Nicolescu G, et al. Entomologic and avian investigations of an epidemic of West Nile fever in Romania in 1996, with serologic and molecular characterization of a virus isolate from mosquitoes. Am J Trop Med Hyg 1999; 61(4): 600-611.
15. Lanciotti RS, Ebel GD, Deubel V, et al. Complete genome sequences and phylogenetic analysis of West Nile virus strains isolated from the United States, Europe, and the Middle East. Virology 2002; 298(1): 96-105.
16. Castillo-Olivares J, Wood J. West Nile virus infection of horses. Vet Res 2004; 35(4): 467-483.
17. Murgue B, Murri S, Zientara S, Durand B, Durand JP, Zeller H. West Nile outbreak in horses in southern France, 2000: the return after 35 years. Emerg Infect Dis 2001; 7(4): 692-696.
18. L'Vov DK, Kovtunov AI, lashkulov KB, et al. [Circulation of West Nile virus (Flaviviridae, Flavivirus) and some other arboviruses in the ecosystems of Volga delta, Volga-Akhtuba flood-lands and adjoining arid regions (2000-2002)]. Vopr Virusol 2004; 49(3): 45-51.
19. Zeller HG, Schuffenecker I. West Nile virus: an overview of its spread in Europe and the Mediterranean basin in contrast to its spread in the Americas. Eur J Clin Microbiol Infect Dis 2004; 23(3): 147-156.
20. Weinberger M, Pitlik SD, Gandacu D, et al. West Nile fever outbreak, Israel, 2000: epidemiologic aspects. Emerg Infect Dis 2001; 7(4): 686-691.
21. Tsai TF, Popovici F, Cernescu C, Campbell GL, Nedelcu NI. West Nile encephalitis epidemic in southeastern Romania. Lancet 1998; 352(9130): 767-771.
22. Turell MJ, O'Guinn ML, Dohm DJ, Webb JP, Jr., Sardelis MR. Vector competence of Culex tarsalis from Orange County, California, for West Nile virus. Vector Borne Zoonotic Dis 2002; 2(3): 193-196.
23. Hayes C. West Nile Fever. In The Arboviruses: Epidemiology and Ecology, Monath T (ed.). CRC Press: Boca Raton, 1989; 59-88.
24. Lawrie CH, Uzcategui NY, Gould EA, Nuttall PA. Ixodid and argasid tick species and west nile virus. Emerg Infect Dis 2004; 10(4): 653-657.
25. Nasci RS, Savage HM, White DJ, et al. West Nile virus in overwintering Culex mosquitoes, New York City, 2000. Emerg Infect Dis 2001; 7(4): 742-744.
26. Komar N, Panella NA, Burns JE, Dusza SW, Mascarenhas TM, Talbot TO. Serologic evidence for West Nile virus infection in birds in the New York City vicinity during an outbreak in 1999. Emerg Infect Dis 2001; 7(4): 621-625.
27. Eidson M, Komar N, Sorhage F, et al. Crow deaths as a sentinel surveillance system for West Nile virus in the northeastern United States, 1999. Emerg Infect Dis 2001; 7(4): 615-620.
28. Marfin AA, Petersen LR, Eidson M, et al. Widespread West Nile virus activity, eastern United States, 2000. Emerg Infect Dis 2001; 7(4): 730-735.
29. Komar N. West Nile viral encephalitis. Rev Sci Tech 2000; 19(1): 166-176.
30. Heinz-Taheny KM, Andrews JJ, Kinsel MJ, et al. West Nile virus infection in free-ranging squirrels in Illinois. J Vet Diagn Invest 2004; 16(3): 186-190.
31. Miller DL, Mauel MJ, Baldwin C, et al. West Nile virus in farmed alligators. Emerg Infect Dis 2003; 9(7): 794-799.
32. Bunning ML, Bowen RA, Cropp CB, et al. Experimental infection of horses with West Nile virus. Emerg Infect Dis 2002; 8(4): 380-386.
33. Rappole JH, Derrickson SR, Hubalek Z. Migratory birds and spread of West Nile virus in the Western Hemisphere. Emerg Infect Dis 2000; 6(4): 319-328.
34. Gubler DJ. Human arbovirus infections worldwide. Ann N Y Acad Sci 2001; 951: 13-24.
35. Estrada-Franco JG, Navarro-Lopez R, Beasley DW, et al. West Nile virus in Mexico: evidence of widespread circulation since July 2002. Emerg Infect Dis 2003; 9(12): 1604-1607.
36. Cruz L, Cardenas VM, Abarca M, et al. Short report: serological evidence of West Nile virus activity in El Salvador. Am J Trop Med Hyg 2005; 72(5): 612-615.
37. Canada H. West Nile Virus Weekly Surveillance Report. West Nile Virus Monitor [Webpage] 2005 [cited 2005 September 6, 2005]; Available from: http://www.phac-aspc.gc.ca/wnv-vwn/mon_e.html#nsr
38. Pealer LN, Marfin AA, Petersen LR, et al. Transmission of West Nile virus through blood transfusion in the United States in 2002. N Engl J Med 2003; 349(13): 1236-1245.
39. Centers for Disease Control and Prevention. Update: West Nile virus screening of blood donations and transfusion-associated transmission-United States, 2003. MMWR Morb Mortal Wkly Rep 2004; 53(13): 281-284.
40. Stramer SL, Fang CT, Foster GA, Wagner AG, Brodsky JP, Dodd RY. West Nile virus among blood donors in the United States, 2003 and 2004. N Engl J Med 2005; 353(5): 451-459.
41. Kleinman S, Glynn SA, Busch M, et al. The 2003 West Nile virus United States epidemic: the America's Blood Centers experience. Transfusion 2005; 45(4): 469-479.
42. Iwamoto M, Jernigan DB, Guasch A, et al. Transmission of West Nile virus from an organ donor to four transplant recipients. N Engl J Med 2003; 348(22): 2196-2203.
43. Centers for Disease Control and Prevention. Intrauterine West Nile virus infection-New York, 2002. MMWK Morb Mortal Wkly Rep 2002; 51(50): 1135-1136.
44. Alpert SG, Fergerson J, Noel LP. Intrauterine West Nile virus: ocular and systemic findings. Am J Ophthalmol 2003; 136(4): 733-735.
45. Mostashari F, Bunning ML, Kitsutani PT, et al. Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological survey. Lancet 2001; 358(9278): 261-264.
46. Centers for Disease Control and Prevention. Serosurveys for West Nile virus infection-New York and Connecticut counties, 2000. MMWR Morb Mortal Wkly Rep 2001; 50(3): 37-39.
47. McCarthy TA, Hadler JL, Julian K, et al. West Nile virus serosurvey and assessment of personal prevention efforts in an area with intense epizootic activity: Connecticut, 2000. Ann N Y Acad Sci 2001; 951: 307-316.
48. Jennifer Brown D. West Nile virus in blood donors: Colorado cohort study, 2003. In Fifth National Conference on West Nile virus in the United States; 1995 February 3-5, 2004; Denver, CO; 1995.
49. Hayes EB, O'Leary DR. West Nile virus infection: a pediatrie perspective. Pediatrics 2004; 113(5): 1375-1381.
50. Southam CM, Moore AE. Clinical studies of viruses as antineoplastic agents with particular reference to Egypt 101 virus. Cancer 1952; 5(5): 1025-1034.
51. Southam CM, Moore AE. Induced virus infections in man by the Egypt isolates of West Nile virus. Am J Trop Med Hyg 1954; 3(1): 19-50.
52. Deubel V, Fiette L, Gounon P, et al. Variations in biological features of West Nile viruses. Ann N Y Acad Sci 2001; 951: 195-206.
53. Sampson BA, Ambrosi C, Charlot A, Reiber K, Veress JF, Armbrustmacher V. The pathology of human West Nile Virus infection. Hum Pathol 2000; 31(5): 527-531.
54. Doron SI, Dashe JF, Adelman LS, Brown WF, Werner BG, Hadley S. Histopathologically proven poliomyelitis with quadriplegia and loss of brain-stem function due to West Nile virus infection. Clin Infect Dis 2003; 37(5): e74-e77.
55. Agamanolis DP, Leslie MJ, Caveny EA, Guarner J, Shieh WJ, Zaki SR. Neuropathological findings in West Nile virus encephalitis: a case report. Ann Neurol 2003; 54(4): 547-551.
56. Cushing MM, Brat DJ, Mosunjac MI, et al. Fatal West Nile virus encephalitis in a renal transplant recipient. Am J Clin Pathol 2004; 121(1): 26-31.
57. Fratkin JD, Leis AA, Stokic DS, Slavinski SA, Geiss RW. Spinal cord neuropathology in human West Nile virus infection. Arch Pathol Lab Med 2004; 128(5): 533-537.
58. Park M, Hui JS, Bartt RE. Acute anterior radiculitis associated with West Nile virus infection. J Neurol Neurosurg Psychiatry 2003; 74(6): 823-825.
59. Bouffard JP, Riudavets MA, Holman R, Rushing EJ. Neuropathology of the brain and spinal cord in human West Nile virus infection. Clin Neuropathol 2004; 23(2): 59-61.
60. Sejvar JJ, Haddad MB, Tierney BC, et al. Neurologic manifestations and outcome of West Nile virus infection. Jama 2003; 290(4): 511-515.
61. Emig M, Apple DJ. Severe West Nile virus disease in healthy adults. Clin Infect Dis 2004; 38(2): 289-292.
62. Pepperell C, Rau N, Krajden S, et al. West Nile virus infection in 2002: morbidity and mortality among patients admitted to hospital in southcentral Ontario. Cmaj 2003; 168(11): 1399-1405.
63. Sayao AL, Suchowersky O, Al-Khathaami A, et al. Calgary experience with West Nile virus neurological syndrome during the late summer of 2003. Can J Neurol Sci 2004; 31(2): 194-203.
64. O'Leary D, Marfin AA, Montgomery SP, et al. The epidemic of West Nile virus infection in the United States, 2002. Vector Borne Zoonotic Dis 2004; 4: 61-70.
65. Hayes EB, Gubler DJ. West Nile Virus: epidemiology and clinical features of an emerging epidemic in the United States. Annu Rev Med 2006; 57: 181-194.
66. Ferguson DD, Gershman K, LeBailly A, Petersen LR. Characteristics of the rash associated with West Nile virus fever. Clin Infect Dis 2005; 41(8): 1204-1207.
67. Del Giudice P, Schuffenecker I, Zeller H, et al. Skin manifestations of west nile virus infection. Dermatology 2005; 211(4): 348-350.
68. Gorsche R, Tilley P. The rash of West Nile virus infection. Cmaj 2005; 172(11): 1440.
69. Anderson RC, Horn KB, Hoang MP, Gottlieb E, Bennin B. Punctate exanthem of West Nile Virus infection: report of 3 cases. J Am Acad Dermatol 2004; 51(5): 820-823.
70. Watson JT, Pertel PE, Jones RC, et al. Clinical characteristics and functional outcomes of West Nile Fever. Ann Intern Med 2004; 141(5): 360-365.
71. Gottfried K, Quinn R, Jones T. Clinical description and follow-up investigation of human West Nile virus cases. South Med J. 2005; 98: 603-606.
72. Crichlow R, Bailey J, Gardner C. Cerebrospinal fluid neutrophilic pleocytosis in hospitalized West Nile virus patients. J Am Board Fam Pract 2004; 17(6): 470-472.
73. Sejvar JJ, Bode AV, Marfin AA, et al. West Nile virus-associated flaccid paralysis. Emerg Infect Dis 2005; 11(7): 1021-1027.
74. Carson PJ, Steidler T, Patron R, Tate JM, Tight R, Smego RA, Jr. Plasma cell pleocytosis in cerebrospinal fluid in patients with West Nile virus encephalitis. Clin Infect Dis 2003; 37(1): e12-e15.
75. Weiss D, Carr D, Kellachan J, et al. Clinical findings of West Nile virus infection in hospitalized patients, New York and New Jersey, 2000. Emerg Infect Dis 2001; 7(4): 654-658.
76. Ravindra KV, Freifeld AG, Kalil AC, et al. West Nile virus-associated encephalitis in recipients of renal and pancreas transplants: case series and literature review. Clin Infect Dis 2004; 38(9): 1257-1260.
77. Armali Z, Ramadan R, Chlebowski A, Azzam ZS. West Nile meningo-encephalitis infection in a kidney transplant recipient. Transplant Proc 2003; 35(8): 2935-2936.
78. Burton JM, Kern RZ, Halliday W, et al. Neurological manifestations of West Nile virus infection. Can J Neurol Sci 2004; 31(2): 185-193.
79. Robinson RL, Shahida S, Madan N, Rao S, Khardori N. Transient parkinsonism in West Nile virus encephalitis. Am J Med 2003; 115(3): 252-253.
80. Kanagarajan K, Ganesh S, Alakhras M, Go ES, Recco RA, Zaman MM. West Nile virus infection presenting as cerebellar ataxia and fever: case report. South Med J 2003; 96(6): 600-601.
81. Gandelman-Marton R, Kimiagar I, Itzhaki A, Klein C, Theitler J, Rabey JM. Electroencephalography findings in adult patients with West Nile virus-associated meningitis and meningoencephalitis. Clin Infect Dis 2003; 37(11): 1573-1578.
82. Brilla R, Block M, Geremia G, Wichter M. Clinical and neuroradiologic features of 39 consecutive cases of West Nile Virus meningoencephalitis. J Neurol Sci 2004; 220(1-2): 37-40.
83. Misra UK, Kalita J. Prognosis of Japanese encephalitis patients with dystonia compared to those with parkinsonian features only. Postgrad Med J 2002; 78(918): 238-241.
84. Rosas H, Wippold FJ, 2nd. West Nile virus: case report with MR imaging findings. AJNR Am J Neuroradiol 2003; 24(7): 1376-1378.
85. Agid R, Ducreux D, Halliday WC, Kucharczyk W, terBrugge KG, Mikulis DJ. MR diffusion-weighted imaging in a case of West Nile virus encephalitis. Neurology 2003; 61(12): 1821-1823.
86. Klee AL, Maidin B, Edwin B, et al. Long-term prognosis for clinical West Nile virus infection. Emerg Infect Dis 2004; 10(8): 1405-1411.
87. Kleinschmidt-DeMasters BK, Marder BA, Levi ME, et al. Naturally acquired West Nile virus encephalomyelitis in transplant recipients: clinical, laboratory, diagnostic, and neuropathological features. Arch Neurol 2004; 61(8): 1210-1220.
88. Jeha LE, Sila CA, Lederman RJ, Prayson RA, Isada CM, Gordon SM. West Nile virus infection: a new acute paralytic illness. Neurology 2003; 61(1): 55-59.
89. Leis AA, Stokic DS, Polk JL, Dostrow V, Winkelmann M. A poliomyelitis-like syndrome from West Nile virus infection. N Engl J Med 2002; 347(16): 1279-1280.
90. Glass JD, Samuels O, Rich MM. Poliomyelitis due to West Nile virus. N Engl J Med 2002; 347(16): 1280-1281.
91. Sejvar JJ, Leis AA, Stokic DS, et al. Acute flaccid paralysis and West Nile virus infection. Emerg Infect Dis 2003; 9(7): 788-793.
92. Li J, Loeb JA, Shy ME, et al. Asymmetric flaccid paralysis: a neuromuscular presentation of West Nile virus infection. Ann Neurol 2003; 53(6): 703-710.
93. Fan E, Needham DM, Brunton J, Kern RZ, Stewart TE. West Nile virus infection in the intensive care unit: a case series and literature review. Can Respir J 2004; 11(5): 354-358.
94. Leis AA, Stokic DS, Webb RM, Slavinski SA, Fratkin J. Clinical spectrum of muscle weakness in human West Nile virus infection. Muscle Nerve 2003; 28(3): 302-308.
95. Al-Shekhlee A, Katirji B. Electrodiagnostic features of acute paralytic poliomyelitis associated with West Nile virus infection. Muscle Nerve 2004; 29(3): 376-380.
96. Ahmed S, Libman R, Wesson K, Ahmed F, Einberg K. Guillain-Barre syndrome: an unusual presentation of West Nile virus infection. Neurology 2000; 55(1): 144-146.
97. Cao NJ, Ranganathan C, Kupsky WJ, Li J. Recovery and prognosticators of paralysis in West Nile virus infection. J Neurol Sci 2005; 236(1-2): 73-80.
98. Hershberger VS, Augsburger JJ, Hutchins RK, Miller SA, Horwitz JA, Bergmann M. Chorioretinal lesions in nonfatal cases of West Nile virus infection. Ophthalmology 2003; 110(9): 1732-1736.
99. Bains HS, Jampol LM, Caughron MC, Parnell JR. Vitritis and chorioretinitis in a patient with West Nile virus infection. Arch Ophthalmol 2003; 121(2): 205-207.
100. Adelman RA, Membreno JH, Afshari NA, Stoessel KM. West Nile virus chorioretinitis. Retina 2003; 23(1): 100-101.
101. Kuchtey RW, Kosmorsky GS, Martin D, Lee MS. Uveitis associated with West Nile virus infection. Arch Ophthalmol 2003; 121(11): 1648-1649.
102. Khairallah M, Ben Yahia S, Ladjimi A, et al. Chorioretinal involvement in patients with West Nile virus infection. Ophthalmology 2004; 111(11): 2065-2070.
103. Kulstad EB, Wichter MD. West Nile encephalitis presenting as a stroke. Ann Emerg Med 2003; 41(2): 283.
104. Perelman A, Stern J. Acute pancreatitis in West Nile Fever. Am J Trop Med Hyg 1974; 23(6): 1150-1152.
105. Heresi GP, Mancias P, Mazur LJ, Butler IJ, Murphy JR, Cleary TG. Poliomyelitis-like syndrome in a child with West Nile virus infection. Pediatr Infect Dis J 2004; 23(8): 788-789.
106. Moon TD, Nadimpalli A, Martin EB, Ortiz MA, Van Dyke RB. Balance and gait abnormalities of a child with West Nile virus infection. Pediatr Infect Dis J 2005; 24(6): 568-570.
107. Debiasi RL, Parsons JA, Grabert BE. West nile virus meningoencephalitis in an immunocompetent adolescent. Pediatr Neurol 2005; 33(3): 217-219.
108. Roehrig JT, Nash D, Maldin B, et al. Persistence of virus-reactive serum immunoglobulin m antibody in confirmed west nile virus encephalitis cases. Emerg Infect Dis 2003; 9(3): 376-379.
109. Kapoor H, Signs K, Somsel P, Downes FP, Clark PA, Massey JP. Persistence of West Nile Virus (WNV) IgM antibodies in cerebrospinal fluid from patients with CNS disease. J Clin Virol 2004; 31(4): 289-291.
110. Martin DA, Biggerstaff BJ, Allen B, Johnson AJ, Lanciotti RS, Roehrig JT. Use of immunoglobulin m cross-reactions in differential diagnosis of human flaviviral encephalitis infections in the United States. Clin Diagn Lab Immunol 2002; 9(3): 544-549.
111. Guyton A. Reaction of the body to poliomyelitis and the recovery process. Arch Int Med 1949; 83: 27.
112. Jordan I, Briese T, Fischer N, Lau JY, Lipkin WI. Ribavirin inhibits West Nile virus replication and cytopathic effect in neural cells. J Infect Dis 2000; 182(4): 1214-1217.
113. Ferrara EA, Oishi JS, Wannemacher RW, Jr., Stephen EL. Plasma disappearance, urine excretion, and tissue distribution of ribavirin in rats and rhesus monkeys. Antimicrob Agents Chemother 1981; 19(6): 1042-1049.
114. Chowers MY, Lang R, Nassar F, et al. Clinical characteristics of the West Nile fever outbreak, Israel, 2000. Emerg Infect Dis 2001; 7(4): 675-678.
115. Morrey JD, Day CW, Julander JG, Blatt LM, Smee DF, Sidwell RW. Effect of interferon-alpha and interferon-inducers on West Nile virus in mouse and hamster animal models. Antivir Chem Chemother 2004; 15(2): 101-109.
116. Solomon T, Dung NM, Wills B, et al. Interferon alfa-2a in Japanese encephalitis: a randomised double-blind placebo-controlled trial. Lancet 2003; 361(9360): 821-826.
117. Diamond MS, Shrestha B, Marri A, Mahan D, Engle M. B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus. J Virol 2003; 77(4): 2578-2586.
118. Shimoni Z, Niven MJ, Pitlick S, Bulvik S. Treatment of West Nile virus encephalitis with intravenous immunoglobulin. Emerg Infect Dis 2001; 7(4): 759.
119. Agrawal AG, Petersen LR. Human immunoglobulin as a treatment for West Nile virus infection. J Infect Dis 2003; 188(1): 1-4.
120. Chung KM, Nybakken GE, Thompson BS, et al. Antibodies against West Nile virus nonstructural protein NS1 prevent lethal infection through Fc gamma receptor-dependent and -independent mechanisms. J Virol 2006; 80(3): 1340-1351.
121. Nasci R. West Nile virus in Fort Collins, CO 2003: Surveillance and Vector Control. In: Fifth National Conference on West Nile virus in the United States; 2004 February 3-5, 2004; Denver, CO; 2004.
122. Centers for Disease Control and Prevention. Knowledge, attitudes, and behaviors about West Nile virus-Connecticut, 2002. MMWR Morb Mortal Wkly Rep 2003; 52(37): 886-888.